benzyl N-[3-[methyl-[6-oxo-2-(phenylmethoxycarbonylcarbamoylamino)-4,5-dihydro-1H-pyrimidin-5-yl]amino]-3-oxopropyl]carbamate | 204584-76-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: benzyl N-[3-[methyl-[6-oxo-2-(phenylmethoxycarbonylcarbamoylamino)-4,5-dihydro-1H-pyrimidin-5-yl]amino]-3-oxopropyl]carbamate
• CAS: 204584-76-9
• 化学式: C₂₅H₂₈N₆O₇
• 分子量: 524.533
• InChiKey: XDROGRAEKRVHLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  38
• 可旋转键数：
  11
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  168
• 氢给体数：
  4
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  benzyl N-[3-[methyl-[6-oxo-2-(phenylmethoxycarbonylcarbamoylamino)-4,5-dihydro-1H-pyrimidin-5-yl]amino]-3-oxopropyl]carbamate 在 palladium dichloride 氢气 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 0.25h， 以25%的产率得到5'S/R-3-amino-N-(2-[aminocarbonyl]amino-1,4,5,6-tetrahydro-4-oxo-5-pyrimidinyl)-N-methyl-propanamide
  参考文献：
  名称：

  Synthesis and Antimicrobial Evaluation of TAN-1057A/B Analogs.

  摘要：

  TAN-1057A∼D, dipeptides isolated from bacteria Flexibacter sp. PK-74 and PK-176, are new antibiotics with potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). We describe, in detail, the synthesis of several TAN-1057A/B analogs by a convergent route featuring a new method to construct the cyclic amidinourea functional group. The biological activity of these substances against methicillin-resistant Staphylococcus aureus (MRSA) is reported.

  DOI：

  10.7164/antibiotics.51.189
• 作为产物：
  描述：

  {3-(3-Benzyloxycarbonylaminocarbonyl-2-methyl-isothioureido)-2-[(3-benzyloxycarbonylamino-propionyl)-methyl-amino]-3-oxo-propyl}-carbamic acid tert-butyl ester 在 三氟乙酸 、 三乙胺 作用下， 以 二氯甲烷 、 四氢呋喃 为溶剂， 反应 0.42h， 以4 mg的产率得到benzyl N-[3-[methyl-[6-oxo-2-(phenylmethoxycarbonylcarbamoylamino)-4,5-dihydro-1H-pyrimidin-5-yl]amino]-3-oxopropyl]carbamate
  参考文献：
  名称：

  Synthesis and Antimicrobial Evaluation of TAN-1057A/B Analogs.

  摘要：

  TAN-1057A∼D, dipeptides isolated from bacteria Flexibacter sp. PK-74 and PK-176, are new antibiotics with potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). We describe, in detail, the synthesis of several TAN-1057A/B analogs by a convergent route featuring a new method to construct the cyclic amidinourea functional group. The biological activity of these substances against methicillin-resistant Staphylococcus aureus (MRSA) is reported.

  DOI：

  10.7164/antibiotics.51.189